Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2024

19-12-2023 | Ehlers-Danlos Syndrome | Original Article

Relationship Between Psychological Trauma and Irritable Bowel Syndrome and Functional Dyspepsia in a Joint Hypermobility Syndrome/Ehlers–Danlos Syndrome Patient Population

Authors: Casey Silvernale, Isabelle Garcia-Fischer, Kyle Staller

Published in: Digestive Diseases and Sciences | Issue 3/2024

Login to get access

Abstract

Background

There is frequent overlap between and the connective tissue diseases Joint Hypermobility Syndrome/Ehlers–Danlos Syndrome (JHS/EDS) and disorders of the gut–brain interaction (DGBIs).

Aims

Because not all JHS/EDS patients develop DGBIs, we sought to determine whether secondary environmental triggers may lead to development of irritable bowel syndrome (IBS) and functional dyspepsia (FD) in patients with JHS/EDS.

Methods

We sent electronic surveys to 253 patients from a JHS/EDS support group, with responses collected over one year. IBS and FD were diagnosed by the Rome IV criteria, with additional validated assessments of adverse childhood experiences (ACEs) and traumatic stressors according to DSM-V criteria. We compared clinical and psychological characteristics of JHS/EDS patients with and without DGBIs using univariable and multivariable analyses.

Results

We enrolled 193 JHS/EDS patients, of whom 67.9% met Rome IV criteria for IBS. The IBS and JHS/EDS overlap group reported significantly more traumatic exposures (P < 0.001) and were more likely to have experienced greater than 3 ACEs (P < 0.001) than JHS/EDS patients without IBS. FD was found in 35.2% of patients and was associated with significantly more traumatic exposures (P < 0.001) and were more likely to have experienced greater than 3 ACEs (P < 0.001) than JHS/EDS patients without FD.

Conclusions

We found that JHS/EDS patients with IBS and FD overlap reported significantly more traumatic exposures and ACEs compared to JHS/EDS patients without overlapping IBS or FD. JHS/EDS patients may have increased susceptibility to DGBIs, with traumatic life experiences and/or ACEs acting a secondary environmental trigger driving the subsequent development of DGBIs.
Literature
1.
go back to reference Fikree A, Grahame R, Aktar R et al. A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. Clinical Gastroenterology and Hepatology. 2014;12:1680–1687.e2.CrossRefPubMed Fikree A, Grahame R, Aktar R et al. A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. Clinical Gastroenterology and Hepatology. 2014;12:1680–1687.e2.CrossRefPubMed
2.
go back to reference Fikree A, Aktar R, Grahame R et al. Functional gastrointestinal disorders are associated with the joint hypermobility syndrome in secondary care: A case–control study. Neurogastroenterology and Motility. 2015;27:569–579.CrossRefPubMed Fikree A, Aktar R, Grahame R et al. Functional gastrointestinal disorders are associated with the joint hypermobility syndrome in secondary care: A case–control study. Neurogastroenterology and Motility. 2015;27:569–579.CrossRefPubMed
3.
go back to reference Castori M, Morlino S, Pascolini G, Blundo C, Grammatico P. Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type. American Journal of Medical Genetics Part C, Seminars in Medical Genetics. 2015;169C:54–75.CrossRefPubMed Castori M, Morlino S, Pascolini G, Blundo C, Grammatico P. Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type. American Journal of Medical Genetics Part C, Seminars in Medical Genetics. 2015;169C:54–75.CrossRefPubMed
4.
go back to reference Zarate N, Farmer AD, Grahame R et al. Unexplained gastrointestinal symptoms and joint hypermobility: Is connective tissue the missing link? Neurogastroenterology & Motility. 2010;22:252–e278.CrossRef Zarate N, Farmer AD, Grahame R et al. Unexplained gastrointestinal symptoms and joint hypermobility: Is connective tissue the missing link? Neurogastroenterology & Motility. 2010;22:252–e278.CrossRef
5.
go back to reference Raghavan S, Bitar KN. The influence of extracellular matrix composition on the differentiation of neuronal subtypes in tissue engineered innervated intestinal smooth muscle sheets. Biomaterials. 2014;35:7429–7440.CrossRefPubMedPubMedCentral Raghavan S, Bitar KN. The influence of extracellular matrix composition on the differentiation of neuronal subtypes in tissue engineered innervated intestinal smooth muscle sheets. Biomaterials. 2014;35:7429–7440.CrossRefPubMedPubMedCentral
6.
go back to reference Burke N, Helmman J, Scott BG, Weems CF, Carrion VG. The impact of adverse childhood experiences on an urban pediatric population. Child Abuse & Neglect 2011;35:408–413.CrossRef Burke N, Helmman J, Scott BG, Weems CF, Carrion VG. The impact of adverse childhood experiences on an urban pediatric population. Child Abuse & Neglect 2011;35:408–413.CrossRef
7.
go back to reference Savas L, White DL, Wieman M, Daci K, Fitzgerald S, Laday Smith S, Tan G, Graham DP, Cully JA, El-Serag HB. Irritable bowel syndrome and dyspepsia among women veterans: Prevalence and association with psychological distress. Alimentary Pharmacology & Therapeutics 2009;29:115–125.CrossRef Savas L, White DL, Wieman M, Daci K, Fitzgerald S, Laday Smith S, Tan G, Graham DP, Cully JA, El-Serag HB. Irritable bowel syndrome and dyspepsia among women veterans: Prevalence and association with psychological distress. Alimentary Pharmacology & Therapeutics 2009;29:115–125.CrossRef
Metadata
Title
Relationship Between Psychological Trauma and Irritable Bowel Syndrome and Functional Dyspepsia in a Joint Hypermobility Syndrome/Ehlers–Danlos Syndrome Patient Population
Authors
Casey Silvernale
Isabelle Garcia-Fischer
Kyle Staller
Publication date
19-12-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08201-y

Other articles of this Issue 3/2024

Digestive Diseases and Sciences 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.